RecruitingNCT05468970

Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue Tumors

Single-center Real World Prospective Observational Study of Clinical Features, Treatment Patterns, and Survival of Bone and Soft Tissue Tumors


Sponsor

Henan Cancer Hospital

Enrollment

6,000 participants

Start Date

Aug 3, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

It is planned to prospectively collect, collate and report real-world clinical data of BSTS patients treated in our hospital in the next ten years to evaluate the changes in clinical characteristics, treatment patterns and survival information of these patients, in order to provide reference for clinical treatment and research of this type of tumor.


Eligibility

Min Age: 6 YearsMax Age: 99 Years

Inclusion Criteria4

  • All ages, male and female.
  • The pathological diagnosis of BSTS in our hospital was a subtype.
  • Has received at least one hospitalization in this hospital.
  • The target lesions could be evaluated according to the efficacy evaluation criteria of solid tumor (RECIST; Version 1.1) Measure diameter changes.

Exclusion Criteria1

  • No definite pathology.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNO Intervention

NO Intervention


Locations(1)

Department of Bone and Soft Tissue ,Henan Cancer Hospital

Zhengzhou, Henan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05468970


Related Trials